RILEXINE 75 MG TABLETS FOR DOGS AND CATS
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
09-11-2016
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
CEFALEXIN (AS CEFALEXIN MONOHYDRATE) PH. EUR
Available from:
Virbac S.A.
ATC code:
QJ01DB01
INN (International Name):
CEFALEXIN (AS CEFALEXIN MONOHYDRATE) PH. EUR
Dosage:
75 mg/tablet
Pharmaceutical form:
Tablets
Prescription type:
POM
Therapeutic group:
Canine, Feline
Therapeutic area:
Cefalexin
Therapeutic indications:
Antibacterial
Authorization status:
Authorised
Authorization date:
1988-10-01
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Rilexine 75 mg Tablets for dogs and cats
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Tablets.
Creamy oblong tablet with small brown spots marked with a score line.
The tablets can be divided into halves.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs and cats
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of bacterial skin infections in dogs (including deep and superficial pyodermas) caused by organisms
susceptible to Cefalexin.
For the treatment of cutaneous and subcutaneous infections (wounds and abscesses) in cats caused by organisms
susceptible to Cefalexin.
For the treatment of urinary-tract infections in cats and dogs (including nephritis and cystitis) caused by organisms
susceptible to Cefalexin.
4.3 CONTRAINDICATIONS
Do not use in animals which are known to be hypersensitive to penicillins and cephalosporins.
Do not use in rabbits, guinea pigs, hamsters and gerbils.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
One tablet contains:
ACTIVE SUBSTANCE:
Cefalexin
75 mg
(as Cefalexin Monohydrate)
For the full list of excipients, see section 6.1.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 25/10/2016_
_CRN 7022708_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
As with other antibiotics which are excreted mainly by the kidneys, unnecessary accumulation may occur in the body
when renal function is impaired. In case of known renal insufficiency, the dose should be reduced and antimicrobials
known to be nephrotoxic should not be administered concurrently.
This product should not be used to treat puppies of less th
Read the complete document
